Given the importance to health policy of having access to the best evidence, and the excellence of biomedical research in Cambridge, it's no surprise that policy makers in this area continue to be strongly represented in CSaP's network.


How to measure what can't easily be measured

A CSaP Policy Workshop to brainstorm ideas on how the NIHR can measure the impact of its interventions brought together academic experts with senior policy makers for an ...


Electronic Cigarettes: a disruptive technology?

Professor Linda Bauld, a former scientific adviser on tobacco control to the UK government, delivered the BHRU annual lecture which this year focused on e-cigarettes and their effectiveness ...


Using computers to understand the language of diseases: capabilities and challenges

The eighth meeting of CSaP's Policy Leaders Fellowship focussed on 'Infection', with a talk by Dr Nigel Collier.


Innovation management by global health entrepreneurs

For diseases like TB, logistical and societal factors may be larger barriers to treatment than either drug innovation or affordability. Julia Fan Li outlined the role that entrepreneurship ...


Could health data generated 'unintentionally' e.g. by analysing Google searches or our shopping basket, tell health……

7 hours ago


Experimental government and public policy series: first talk on public health crises in humanitarian zones Fri 5 Oc……

2 weeks, 1 day ago


Realising genomic medicine: intellectual property issues

On 1 May the Centre for Science and Policy hosted a workshop in association with the Centre for Law Medicine and Life Sciences at the University of Cambridge. ...